Peter J. Siska

机构：University Hospital Regensburg · ORCID：0000-0002-1521-6213

发表论文 98 篇 · 总被引 4792 次 · h-index 29

代表论文

• MCT4 blockade increases the efficacy of immune checkpoint blockade (2023 · Journal for ImmunoTherapy of Cancer · 被引 122)
• Targeting strategies in the treatment of fumarate hydratase deficient renal cell carcinoma (2022 · Frontiers in Oncology · 被引 35)
• Integrated single-cell profiling dissects cell-state-specific enhancer landscapes of human tumor-infiltrating CD8+ T cells (2023 · Molecular Cell · 被引 33)
• A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinoma (2023 · Frontiers in Immunology · 被引 30)
• The CD70–CD27 Axis in Cancer Immunotherapy: Predictive Biomarker and Therapeutic Target (2025 · Clinical Cancer Research · 被引 17)
• D-2-hydroxyglutarate supports a tolerogenic phenotype with lowered major histocompatibility class II expression in non-malignant dendritic cells and acute myeloid leukemia cells (2024 · Haematologica · 被引 13)